Gibson William S, Rusheen Aaron E, Oh Yoonbae, In Myung-Ho, Gorny Krzysztof R, Felmlee Joel P, Klassen Bryan T, Jung Sung Jun, Min Hoon-Ki, Lee Kendall H, Jo Hang Joon
Departments of1Neurologic Surgery.
2Department of Neurological Surgery, Northwestern University, Evanston, Illinois; and.
J Neurosurg. 2021 May 14;135(6):1771-1779. doi: 10.3171/2020.10.JNS202277. Print 2021 Dec 1.
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established neurosurgical treatment for the motor symptoms of Parkinson's disease (PD). While often highly effective, DBS does not always yield optimal therapeutic outcomes, and stimulation-induced adverse effects, including paresthesia, muscle contractions, and nausea/lightheadedness, commonly occur and can limit the efficacy of stimulation. Currently, objective metrics do not exist for monitoring neural changes associated with stimulation-induced therapeutic and adverse effects.
In the present study, the authors combined intraoperative functional MRI (fMRI) with STN DBS in 20 patients with PD to test the hypothesis that stimulation-induced blood oxygen level-dependent signals contained predictive information concerning the therapeutic and adverse effects of stimulation.
As expected, DBS resulted in blood oxygen level-dependent activation in myriad motor regions, including the primary motor cortex, caudate, putamen, thalamus, midbrain, and cerebellum. Across the patients, DBS-induced improvements in contralateral Unified Parkinson's Disease Rating Scale tremor subscores correlated with activation of thalamic, brainstem, and cerebellar regions. In addition, improvements in rigidity and bradykinesia subscores correlated with activation of the primary motor cortex. Finally, activation of specific sensorimotor-related subregions correlated with the presence of DBS-induced adverse effects, including paresthesia and nausea (cerebellar cortex, sensorimotor cortex) and unwanted muscle contractions (caudate and putamen).
These results suggest that DBS-induced activation patterns revealed by fMRI contain predictive information with respect to the therapeutic and adverse effects of DBS. The use of fMRI in combination with DBS therefore may hold translational potential to guide and improve clinical stimulator optimization in patients.
丘脑底核(STN)的深部脑刺激(DBS)是治疗帕金森病(PD)运动症状的一种既定神经外科治疗方法。虽然通常非常有效,但DBS并不总能产生最佳治疗效果,且刺激引起的不良反应,包括感觉异常、肌肉收缩和恶心/头晕,很常见且会限制刺激的疗效。目前,不存在用于监测与刺激诱导的治疗和不良反应相关的神经变化的客观指标。
在本研究中,作者将术中功能磁共振成像(fMRI)与20例PD患者的STN DBS相结合,以检验以下假设:刺激诱导的血氧水平依赖信号包含有关刺激的治疗和不良反应的预测信息。
正如预期的那样,DBS导致多个运动区域出现血氧水平依赖激活,包括初级运动皮层、尾状核、壳核、丘脑、中脑和小脑。在所有患者中,DBS诱导的对侧统一帕金森病评定量表震颤亚评分的改善与丘脑、脑干和小脑区域的激活相关。此外,强直和运动迟缓亚评分的改善与初级运动皮层的激活相关。最后,特定感觉运动相关亚区域的激活与DBS诱导的不良反应的存在相关,包括感觉异常和恶心(小脑皮层、感觉运动皮层)以及不必要的肌肉收缩(尾状核和壳核)。
这些结果表明,fMRI显示的DBS诱导激活模式包含有关DBS治疗和不良反应的预测信息。因此,将fMRI与DBS结合使用可能具有转化潜力,以指导和改善患者的临床刺激器优化。